Loading cancer entity…
Loading cancer entity…
Clinical trials
12 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02306512 | Mohs and Immunofluorescence for Malignant Melanoma In Situ | withdrawn | N/A | 0 | University of MiamiOTHER | 1 | Jan 7, 2019 | clinicaltrials |
| NCT00707174 | Combination Therapy With Imiquimod Cream 5% and Tazarotene Cream 0.1% for the Treatment of Lentigo Maligna | completed | N/A | 90 | University of UtahOTHER | 1 | Jul 31, 2013 | clinicaltrials |
| NCT00785369 |
| In Vivo Confocal Microscopy for Pigmented Lesion Diagnosis |
| completed |
| N/A |
| 441 |
| Lucid, Inc.INDUSTRY |
| 1 |
| Oct 3, 2012 |
| clinicaltrials |
Data updated 22 days agoSource updated Jan 7, 2019source: clinicaltrials